Nevertheless, in established serine synthesis-deficient tumor xenografts, acute silencing of SLC6A14/SLC12A4 and to a lesser degree SLC6A14/SLC25A15 reduced tumor growth and serine levels, despite a large proportion of DOX escapers. This evidence concerns the gene SLC6A14 and neoplasm.